The Role of the IL‐33/ST2 Axis in Nervous System Development and Diseases
Immunology & Cell Biology · 2026
DOI: 10.1111/imcb.70138 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology & Cell Biology, 2026. Verfasst von Zhoutong Luo und 1 weiteren Autor:innen. Beteiligte Einrichtung: First School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Interleukin-33, Interleukin-1 Receptor-Like 1 Protein, Nervous System Diseases, Nervous System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guangdong Pharmaceutical University.
Abstract (Originalsprache)
Interleukin (IL)‐33, a cytokine belonging to the IL‐1 family, is produced in various tissues, including the nervous system. As a nuclear‐stored alarmin protein, IL‐33 is released under cell stress or damage, triggering immune responses through its receptor complex, composed of ST2L and the IL‐1 receptor accessory protein (IL‐1RAcP). The receptors for IL‐33 are expressed in various cell types within the nervous system, including neurons, astrocytes, and microglia, and play a crucial role in neurodevelopment and the pathogenesis of neurological diseases. In neurodevelopment, IL‐33 promotes microglial metabolic adaptation and phagocytosis via the IL‐33/ST2/Akt axis, modulates glial function to affect neural circuit maturation, and influences oligodendrocyte differentiation. In neurological disorders, IL‐33 exerts context‐dependent regulatory effects in the nervous system through modulation of myeloid and T‐cell responses, maintenance of barrier integrity, promotion of tissue repair, and regulation of neuroimmune homeostasis. In acute CNS injuries such as ischemic stroke and traumatic brain injury, IL‐33 is generally associated with anti‐inflammatory polarization and enhanced repair, although circulating levels may also reflect injury severity. In chronic neurodegenerative diseases including Alzheimer's and Parkinson's disease, IL‐33 is implicated in amyloid‐β clearance, remyelination, glymphatic function, and neuroprotection, while dysregulation of the IL‐33/sST2 axis correlates with disease progression. In contrast, IL‐33 may facilitate tumor progression in glioma. Emerging evidence also supports IL‐33 and sST2 as potential biomarkers for diagnosis and prognosis in CNS disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
- Department of Anatomy, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou, Guangdong, China.
ORCID-Profile: Zhoutong Luo, Junhua Yang
Förderung
- Guangdong Pharmaceutical University
Zitieren
APA
Luo, Z., & Yang, J. (2026). The Role of the IL‐33/ST2 Axis in Nervous System Development and Diseases. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70138
Vancouver
Luo Z, Yang J. The Role of the IL‐33/ST2 Axis in Nervous System Development and Diseases. Immunology & Cell Biology. 2026. doi:10.1111/imcb.70138
BibTeX
@article{Luo2026,
author = {Luo, Zhoutong and Yang, Junhua},
title = {The Role of the IL‐33/ST2 Axis in Nervous System Development and Diseases},
journal = {Immunology & Cell Biology},
year = {2026},
doi = {10.1111/imcb.70138}
}
EUVIMED